A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
מצבים רפואיים
Cancer · Cancer, Lung
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Jacob Thomas, MD)Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Contact: Principal Investigator (Carlos R Becerra, MD)UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, United States
Contact: Principal Investigator (Lee S. Rosen, MD)Sarah Cannon Research Institute (SCRI) at HealthONE, Denver, Colorado, United States
Contact: Principal Investigator (Gerald Falchook, MD, MS)AdventHealth Cancer Institute, Celebration, Florida, United States
Contact: Principal Investigator (Guru P. Sonpavde, MD)Florida Cancer Specialists, Sarasota, Florida, United States
Contact: Principal Investigator (Manish Patel, MD)Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
Contact: Principal Investigator (Konstantin Dragnev, MD)Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Anshu Giri, MD)SCRI Oncology Partners, Nashville, Tennessee, United States
Contact: Principal Investigator (Melissa L Johnson, MD)NEXT Dallas, Dallas, Texas, United States
Contact: Study coordinator (Shiraj Sen, MD)NEXT Virginia, Fairfax, Virginia, United States
Contact: Principal Investigator (Alex Spira, MD)Cross Cancer Institute, Edmonton, Alberta, Canada
Contact: Principal Investigator (Quincy Chu, MD)Juravinski Cancer Centre, Hamilton, Ontario, Canada
Contact: Principal Investigator (Rosalyn Juergens, MD, PhD)Princess Margaret Cancer Centre - University Health Network, Toronto, Ontario, Canada
Contact: Principal Investigator (Laswson Eng, MD)